Changes in urinary 6beta-hydroxycortisol/cortisol ratio after birth in human neonates

Area of Science:

• Pharmacology and Toxicology
• Neonatal Physiology
• Enzyme Kinetics

Background:

• Cytochrome P450 3A (CYP3A) enzymes play a crucial role in drug metabolism.
• Assessing CYP3A activity in neonates is important due to their unique physiological state and potential drug exposure.
• The urinary 6beta-hydroxycortisol/cortisol (6beta-OHF/C) ratio is a validated biomarker for estimating CYP3A enzyme activity.

Purpose of the Study:

• To evaluate CYP3A enzyme activity in human neonates using the urinary 6beta-OHF/C ratio.
• To compare CYP3A activity between mature and premature neonates on the day of birth and assess changes postnatally.
• To investigate the correlation of urinary 6beta-OHF/C ratios with gestational age, birth weight, and delivery mode.

Main Methods:

• The urinary 6beta-OHF/C ratio was measured in 94 neonates on the day of birth.
• Changes in the ratio were tracked in 81 neonates postnatally.
• Statistical analyses were performed to correlate ratios with clinical parameters like gestational age, birth weight, and delivery mode.

Main Results:

• On the day of birth, urinary 6beta-OHF/C ratios positively correlated with gestational age and birth weight.
• Mature neonates exhibited higher urinary 6beta-OHF/C ratios than premature neonates and adults on the day of birth.
• Within 5 days, ratios in mature neonates decreased to adult levels, while premature neonates showed minimal change over 14 days.

Conclusions:

• On the day of birth, mature neonates likely have higher CYP3A enzyme activity than premature neonates.
• CYP3A enzyme activity in mature neonates undergoes rapid changes in the early postnatal period.
• The urinary 6beta-OHF/C ratio is a useful tool for assessing neonatal CYP3A activity and its developmental trajectory.